Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.11.12.764519

Multi-omic longitudinal profiling of companion dogs reveals cross-omic coordination and structured aging trajectories

Abstract

Aging is a systems-level biological process shaped by coordinated changes across molecular, physiological, and environmental domains, yet how these domains interact and impact aging remains poorly understood. Companion dogs offer a powerful model for addressing this gap, combining shared human environments with diversity in genetics, lifespan, and disease susceptibility. Here, we present a longitudinal multi-omic analysis of aging in 965 companion dogs from the Dog Aging Project, integrating microbiome, epigenome, blood metabolome, and immune phenotyping with extensive clinical, environmental, and lifestyle surveys. We reveal an interconnected cross-omic architecture, with age emerging as the dominant axis of biological variation. We further identify a predictive multi-omic aging signature, distinguish linear from non-linear aging trajectories, uncover breed size-dependent dynamics, and characterize omic-specific mortality risk. Collectively, our findings reveal organizing principles of aging, many paralleling human observations, provide a unique resource for integrative geroscience, and establish dogs as a translational model for aging research.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bamberger, T., Algavi, Y. M., Muller, E., Peleg, O., Baum, S., Greenier, A., Adjangba, C., Slikas, E., Brassington, L., Mariner, B., McCoy, B., Harrison, B. R., Partida-Aguilar, M., Marye, A., Harris, A., Rout, E., DAP Consortium,, Avery, A., Promislow, D. E. L., Snyder-Mackler, N., Borenstein, E.. 2026-11-16. Multi-omic longitudinal profiling of companion dogs reveals cross-omic coordination and structured aging trajectories. https://doi.org/10.64898/2026.11.12.764519

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Benchmarking temporal causal discovery for fully and partially observed biochemical kinetic models

Accurately reconstructing networks of biochemical reactions is a crucial yet unsolved problem for leveraging advances in experimental techniques that track intracellular dynamics in a time-resolved fashion. This task is further challenged by the fact that we typically observe only part of the system, while many variables shaping the dynamics remain unobserved. Causal discovery methods can infer causal relations from purely observational data and account for unobserved variables. They therefore hold promise for yielding faithful, mechanistically interpretable representations of underlying biochemical interactions, but their potential in this context remains underexplored. In this work, we provide a systematic benchmark of state-of-the-art temporal causal discovery methods (tMIIC, PCMCI+/LPCMCI and SVAR-FCI) on time-series data from simulations of biochemical kinetics of mass action and Michaelis-Menten type modelled as systems of nonlinear stochastic differential equations, including an experimentally calibrated model of the epidermal growth factor receptor signalling network. By selectively omitting data, we consider the problem of reconstructing these networks in the presence of both latent confounders and unobserved species participating in reactions. We find that tMIIC and PCMCI+/LPCMCI achieve the highest overall prediction quality, with tMIIC able to handle larger samples within the same runtime budget. We identify, as the main condition for optimal performance of causal discovery, the consistency between data-sampling regimes (sampling intervals, trajectory length) and the typical timescales of the system. We establish that causal discovery can detect latent confounders via bidirected edges and unobserved species via time-delayed edges, locating hidden effects and encoding information on their typical timescales, provided that the data sampling guarantees adequate temporal resolution. As such, our results can guide the choice of hyperparameters in causal discovery algorithms and of data-sampling regimes to optimize network-reconstruction performance.

systems biology↗

Dynamic multi-omics analysis of Adenovirus-induced rAAV-producing stable cell lines reveals the interplay between adenoviral infection and host cell metabolism

Recombinant adeno-associated viruses (rAAV) are invaluable delivery vehicles for gene therapy. However, to make rAAV-based therapies more accessible, there is a need to increase rAAV titers. Here we analyze the phenotypic variation among 30 Adenovirus-induced stably-transfected human producer cell clones to identify metabolic signatures associated with high vs low rAAV production. Exometabolomic characterization revealed decreased amino acid consumption in higher producers. Analysis of RNA-Seq data in the context of a genome-scale metabolic model identified upregulated carnosine biosynthesis-associated pathways during the first 6 hours post infection with adenovirus, relative to uninfected growth. Meanwhile, late infection timepoints exhibited increased amino acid release and de novo biosynthesis of serine, glycine, and arginine. Moreover, high producers decreased expression of genes linked with cholesterol biosynthesis and increased HMG-CoA degradation via HMGCL. Furthermore, sphingosine and ceramide biosynthesis genes were altered in high-producers in directions previously reported to resist cell death and suppress immune signaling. Overall, these findings elucidate the metabolic modulation upon adenoviral infection in a helper virus-induced AAV production process using stably transfected human cell lines.

systems biology↗

Flux analysis resolves distinct brain uptake and clearance of TfR- and CD98hc-targeting large molecules

Advances in large-molecule delivery across the blood-brain barrier (BBB) by targeting receptors such as transferrin receptor (TfR) or CD98 heavy chain (CD98hc) are shifting the focus from restricted parenchymal access toward brain exposure profiles tailored to therapeutic needs. However, brain concentrations offer only partial insight into delivery mechanisms, as they reflect the net balance of two dynamic processes: flux of molecules entering and leaving the brain, here termed brain uptake and brain clearance, respectively. Here, we establish a generalizable experimental and mathematical modeling framework to resolve these opposing fluxes and demonstrate its application using pharmacokinetic (PK) data from Fc-engineered antibody transport vehicles (ATVs) targeting TfR or CD98hc in humanized knock-in mouse models. First, to directly estimate brain clearance, we engineered anti-ATV antibodies that selectively bind the TV patch to block receptor-mediated brain uptake in vivo. Integrating these measurements with a mechanistic PK model, we then reconstructed brain fluxes of ATV molecules over time across a broad range of receptor affinities. Results demonstrated that TfR-targeting promotes rapid, affinity-dependent brain uptake accompanied by comparatively rapid brain clearance, whereas CD98hc-targeting results in slower brain uptake and prolonged retention. Extending this framework to dual TfR/CD98hc-targeting ATVs suggested that higher observed brain exposure relative to single-receptor formats does not necessarily translate to greater brain delivery: increased exposure was predicted to arise primarily from reduced brain clearance, associated with CD98hc-mediated retention, rather than enhanced uptake through dual-receptor engagement. Together, these results establish a quantitative basis for resolving brain fluxes and engineering brain-targeted biologics for desired therapeutic outcomes.

systems biology↗